The frequency of APOE4 carriers was significantly higher among AD patients (7 APOE-ε4/ε3, 1 APOE-ε4/ε4, and 3 APOE-ε3/ε3), whereas all control individuals were APOE-ε3/ε3. Here, APOE is linked to Alzheimer disease.